NCT07322991

Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

A Phase 1 Clinical Trial With an Open-label, Single-agent Repeated Dosing Followed by Combined Repeated Dosing Design to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Il-Yang Pharm. Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this stud is to evaluate the drug-drug interaction between IY001 and IY002 in adult males.

Detailed description

The study is an Open-label, Phase I, drug-drug interaction study.

Conditions

• Healthy Adult Male

Interventions

Type	Name	Description
DRUG	IY001(Finasteride)	Subjects will receive IY001 once daily for 3 days, followed by co-administration of IY001 and IY002 once daily for 5 days.
DRUG	IY002(Tamsulosin)	Subjects will receive IY002 once daily for 5 days, followed by co-administration of IY001 and IY002 once daily for 3 days.

Timeline

• Start date: 2025-10-14
• Primary completion: 2025-12-01
• Completion: 2025-12-01
• First posted: 2026-01-07
• Last updated: 2026-01-07

Locations

1 site across 1 country: South Korea